CVAT Cavitation Technologies, Inc.
Agricultural Services · OTC · SEC CIK 1376793 · Fiscal year ends 06/30
Financial factors as of 2026-06-30 (2026Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY-98.5%
TTM net income YoY-1,142.5%
TTM EPS YoY—
Revenue 3-yr CAGR-80.6%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-46,266.7%
Net margin-46,800.0%
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-821.1%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets1,640.0%
Debt / equity—
Current ratio0.06x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.54x
Accruals ratio-379.5%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-30 | FY20252025-06-30 | FY20242024-06-30 | FY20232023-06-30 | FY20222022-06-30 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3,000 | $203,000 | $1.36M | $433,000 | $1.62M |
| Cost of revenue | $0 | $38,000 | $156,000 | $121,000 | $41,000 |
| Gross profit | $3,000 | $165,000 | $1.21M | $312,000 | $1.62M |
| R&D expense | $11,000 | $95,000 | $61,000 | $3,000 | $17,000 |
| SG&A expense | $1.38M | $1.06M | $708,000 | $1.20M | $1.73M |
| Operating income | -$1.39M | -$987,000 | $438,000 | -$886,000 | -$299,000 |
| Interest expense | — | $6,000 | -$1,000 | $6,000 | $5,000 |
| Pretax income | — | — | — | -$2.04M | -$619,000 |
| Income tax | $0 | $0 | — | $0 | $0 |
| Net income | -$1.40M | -$113,000 | $439,000 | -$2.04M | -$619,000 |
| EBITDA | — | -$987,000 | $439,000 | -$883,000 | -$299,000 |
| EPS (basic) | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS (diluted) | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Weighted avg. shares (diluted) | 303.33M | 286.00M | 284.29M | 281.69M | 248.74M |
| Balance sheet | |||||
| Cash & equivalents | $17,000 | $249,000 | $179,000 | $18,000 | $441,000 |
| Receivables | $0 | $10,000 | $0 | $0 | $1,000 |
| Inventory | — | — | $0 | $0 | $48,000 |
| Current assets | $34,000 | $286,000 | $195,000 | $18,000 | $528,000 |
| PP&E, net | — | — | $0 | $1,000 | $4,000 |
| Total assets | $45,000 | $297,000 | $248,000 | $143,000 | $1.87M |
| Current liabilities | $588,000 | $78,000 | $598,000 | $864,000 | $558,000 |
| Long-term debt | $150,000 | $150,000 | $130,000 | $145,000 | $150,000 |
| Total debt | $150,000 | $150,000 | $130,000 | $145,000 | $150,000 |
| Total liabilities | $738,000 | $228,000 | $728,000 | $1.06M | $835,000 |
| Shareholders' equity | -$693,000 | $69,000 | -$480,000 | -$919,000 | $1.04M |
| Net debt | $133,000 | -$99,000 | -$49,000 | $127,000 | -$291,000 |
| Shares outstanding | 317.22M | 289.16M | 284.29M | 284.29M | 276.70M |
| Cash flow statement | |||||
| Operating cash flow | -$755,000 | -$806,000 | $172,000 | -$423,000 | -$484,000 |
| Investing cash flow | $0 | $880,000 | $0 | $0 | -$1.22M |
| Financing cash flow | $523,000 | -$4,000 | -$11,000 | $0 | $785,000 |
| Depreciation & amortization | — | $0 | $1,000 | $3,000 | $0 |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.